/The%20front%20of%20a%20Rocket%20Lab%20corporate%20office%20by%20Emagnetic%20via%20Shutterstock.jpg)
Rocket Lab (RKLB) shares are in focus on Aug. 13 after the company disclosed a replacement dollar-for-dollar $1.94 billion at-the-market (ATM) equity distribution program. The agreement is designed to fund its pending acquisition of Iridium Communications and reduce debt. In its filing, RKLB also confirmed that the Hart-Scott-Rodino waiting period for the deal has expired.
Rocket Lab stock remains down about 45% versus its year-to-date high.
What the Announcement Means for Rocket Lab Stock
Investors cheered the secondary share offering announcement as it doesn’t come with dilution risk; it simply carries forward the remaining $1.94 billion unsold balance from its prior May agreement.
More importantly, clearing the antitrust HSR review and filing Form S-4 significantly de-risks the proposed transaction with Iridium Communications.
Coupled with a massive $2.4 billion contract backlog and record Q2 revenue of $234 million — up 62% year-over-year — the equity distribution pact reinforces RKLB’s path to becoming a vertically integrated space ecosystem.
It’s positive for Rocket Lab shares because the company can now flexibly deploy capital to scale launch cadence and secure predictable, recurring space systems revenue.
Is It Worth Investing in RKLB Shares Today?
The momentum seen in RKLB shares today is compelling, though near-term concerns demand caution.
On the one hand, the firm commands an enviable moat in small-satellite launch services, expanding defense contract momentum (SDA and MACH-TB), and significant sales upside once the medium-lift Neutron rocket achieves orbit.
But on the other hand, management’s Q3 muted gross margin guidance (29% to 31%) reflects temporary pressure from sales of lower-profit satellite platforms.
The profitability concerns are particularly significant given Rocket Lab currently trades at a price-to-sales (P/S) multiple of about 77x, which makes it a very expensive stock to own by any stretch of the imagination.
How Wall Street Recommends Playing Rocket Lab
Investors should note, however, that Wall Street analysts believe the sell-off in RKLB stock since late May has gone a bit too far and the company is actually undervalued at current levels.
The consensus rating on Rocket Lab sits at “Strong Buy” as of this writing, with the mean price objective of about $114 indicating potential for a more than 40% rally from here.
On the date of publication, Wajeeh Khan did not have (either directly or indirectly) positions in any of the securities mentioned in this article. All information and data in this article is solely for informational purposes. For more information please view the Barchart Disclosure Policy here.
